Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The World Health Organization (WHO) notes that diabetes, a chronic disease, is a silent epidemic, and by 2020 there will be a 54% rise in the total number of individuals diagnosed with this disease (WHO 2017). These are alarming figures, which have significant repercussions for the quality of life of individuals and their families as well as for the financial stress of healthcare systems globally. Early detection and proactive management of diabetes is essential. Objective: The aim of the study was to assess the usability, acceptability and fidelity of Diabetes Monitoring Device (DiaMonD) for patients with gestational diabetes mellitus (GDM). Specifically assessed were: 1) Patient compliance, 2) Patient satisfaction, 3) Level of Glycaemic control achieved, and 4) Health professional satisfaction. Methods: Using a design science research perspective, the Diabetes Monitoring Device (DiaMonD) solutions was adapted to the Australian healthcare environment. Once the solution was deemed fit for purpose by the director of the OBGYN clinical institute and on securing all relevant ethics approvals, a two-period two-arm non-blinded cross over clinical trial was conducted for 8 weeks total time with cross over at 4 weeks to establish proof of concept, usability and fidelity. The patient perspective was assessed by using structured questionnaires at four specific stages of the project while the clinician perspective was captured via semi-structured interviews and unstructured questionnaires. Results: The ten patients studied reported preferring standard care with the technology solution to standard care alone. Further, all the clinicians involved concurred that the technology solution greatly assisted their ability to provide higher value patient centred care. They also noted that it was extremely helpful for assisting in systematically monitoring glucose levels and any/all changes and trends. Conclusions: Based on these inital findings, we proffer a holistic pervasive approach to enable the achievement of value-based, patient-cantred care in chronic disease management. Key lessons include the importance when designing such solutions to focuss on the two primary user groups (patients and clinicians. Clinical Trial: Epworth HREC